Evidence map›Paper›PMID 41313181›Full record

ArticlemBio2026

Dual mode of delivery of

K Sreenath, Linbo Li, Danielle Molotsky, Jason Ayo, Joel B Baseman, T R Kannan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. A multi-epitope vaccine targetingFrontiers in immunology · 2026
    Article
  3. Frontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

K SreenathDepartment of Microbiology, Immunology and Molecular Genetics, The University of Texas at San Antonio, San Antonio, Texas, USA.ORCID 0000-0002-0507-1970
Linbo LiDepartment of Microbiology, Immunology and Molecular Genetics, The University of Texas at San Antonio, San Antonio, Texas, USA.
Danielle MolotskyDepartment of Microbiology, Immunology and Molecular Genetics, The University of Texas at San Antonio, San Antonio, Texas, USA.
Jason AyoDepartment of Microbiology, Immunology and Molecular Genetics, The University of Texas at San Antonio, San Antonio, Texas, USA.
Joel B BasemanDepartment of Microbiology, Immunology and Molecular Genetics, The University of Texas at San Antonio, San Antonio, Texas, USA.
T R KannanDepartment of Microbiology, Immunology and Molecular Genetics, The University of Texas at San Antonio, San Antonio, Texas, USA.ORCID 0000-0003-4590-3951

Funding

Unique ADP-ribosylating and vacuolating properties of Mycoplasma pneumoniae CARDS toxin trigger airway inflammation and disease progressionR01AI141877 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KANNAN, THIRUMALAI RENGASAMY · 2019 to 2023
$2.3M
NIAID NIH HHS R01 AI141877
6 · The paper itself

Abstract

IMPORTANCE:

Indexed as

Bacterial ProteinsBacterial ToxinsMycoplasma pneumoniaeCell LineEpithelial CellsExtracellular VesiclesHost-Pathogen InteractionsHumansPneumonia, MycoplasmaProtein TransportBacterial ProteinsBacterial ToxinsCARDS toxin, Mycoplasma pneumoniaeADP-ribosylationCARDS toxincytotoxicityextracellular vesiclesminimal mediaMycoplasma pneumoniaeprotein secretionvacuolation

Identifiers

PMID41313181
PMCPMC12802180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.